Home » Topics » Conferences

Conferences
RSS

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Resveratrol found in edible peanuts

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Sleep-promoting effects of L-846 demonstrated in insomniac patients

Sep. 8, 1997

Spotlight on adenosine A1 receptor agonists

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...